Rezolute's slogan, "Rezolute is developing transformative therapeutics for rare and metabolic diseases," encapsulates its commitment to pioneering advancements in treating complex medical conditions. The company's United States headquarters serves as the hub for its research, development, and strategic operations. With a sharp focus on leveraging cutting-edge science and technology, Rezolute endeavors to unlock new possibilities in the realm of biopharmaceuticals. To learn more about Rezolute and its groundbreaking initiatives, visit www.rezolutebio.com.
Rezolute, Inc.
Rezolute is developing transformative therapeutics for rare and metabolic diseases.
Founded 2010
Redwood City, United States
66 employees
Post-IPO Equity
Total: $356.00M
Biotechnology, Health Care +1
Redwood City, United States
66 employees
Post-IPO Equity
Total: $356.00M
Biotechnology, Health Care +1
General Information
Company Name
Rezolute, Inc.
Founded Year
2010
Location
Redwood City, United States
Redwood City, United States
Founders / Decision Makers
Employees
66
Industries
Biotechnology, Health Care, Health and Wellness
Funding Stage
Post-IPO Equity
BounceWatch is an independent company data service, not affiliated with Rezolute, Inc.. To contact Rezolute, Inc., visit rezolutebio.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
United States Market
Biotechnology
About Rezolute, Inc.
Taxonomy: clinical-stage biopharmaceutical company, drug development, metabolic diseases, orphan diseases, therapeutics, antibody therapy, diabetes management, rare diseases, plasma kallikrein inhibitor, clinical trials, biopharma innovation, patient-focused therapies
Funding Rounds & Investors (15)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Post IPO Equity | $56.40M | - |
|
13 Jun 2024 |
| Post IPO Equity | $130.00M | - |
|
01 May 2022 |
| Post IPO Equity | $55.00M | - |
|
13 Oct 2021 |
| Post IPO Equity | $41.00M | 4 |
|
09 Oct 2020 |
| Post IPO Equity | $25.00M | 2 |
|
07 Jan 2019 |
| Convertible Note | $5.00M | 1 |
|
03 Apr 2018 |
| Post IPO Equity | $13.00M | 3 |
Medici Investment, Ildong Pharmaceutical +1
|
17 Jul 2017 |
| Post IPO Equity | $6.70M | - |
|
05 Jun 2017 |
| Post IPO Equity | $4.35M | - |
|
21 Mar 2016 |
| Post IPO Equity | $2.00M | - |
|
16 Apr 2015 |
Rezolute, Inc. Alternatives & Competitors
View All Alternatives
Rezolute, Inc. vs
Developing innovative therapies to treat and cure rare metabolic diseases
Post-IPO Debt
25 employees
Biotechnology, Health Care
Rezolute, Inc. vs
Allena Pharmaceuticals, Inc.
United States
Developing Therapeutics for Patients with Rare and Severe Metabolic and Kidney Disorders
Post-IPO Equity
13 employees
Biotechnology, Health and Wellness
Rezolute, Inc. vs
Soligenix, Inc.
United States
We are a late-stage biopharmaceutical company focused on developing & commercializing products to tr...
Post-IPO Equity
27 employees
Biopharma, Biotechnology
Avalo Therapeutics
FAQ About Rezolute, Inc.
Rezolute is developing transformative therapeutics for rare and metabolic diseases.
Rezolute, Inc. was founded in 2010.
Rezolute, Inc. is headquartered in Redwood City, United States.
Rezolute, Inc. operates in Biotechnology, Health Care and Health and Wellness. Its work centres on clinical-stage biopharmaceutical company, drug development, metabolic diseases and orphan diseases.
Rezolute, Inc. has approximately 66 employees.
Rezolute, Inc. has completed 15 funding rounds, raising a total of $356.00M. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to Rezolute, Inc. include Eiger BioPharmaceuticals, Allena Pharmaceuticals, Inc., Soligenix, Inc., Eloxx Pharmaceuticals, Therachon. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Rezolute, Inc. and Eiger BioPharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for Rezolute, Inc., https://bouncewatch.com/company/rezolute-inc, updated 30 December 2024. When citing, please name BounceWatch and link this page.
